Nonparametric statistical methods for cost-effectiveness analyses

Biometrics

Volumn 62, Issue 2, 2006, Pages 576-588

  Dinh, Phillip ^a   Zhou, Xiao Hua ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Confidence interval; Cost effectiveness analysis; Edgeworth expansion; Incremental cost effectiveness ratio; Net health benefit; Skewness

Indexed keywords

ACCELERATION; COST EFFECTIVENESS; FINANCIAL DATA PROCESSING;

CONFIDENCE INTERVAL; COST EFFECTIVENESS ANALYSIS; COST-EFFECTIVENESS RATIOS; EDGEWORTH EXPANSION; HEALTH BENEFITS; INCREMENTAL COST; INCREMENTAL COST-EFFECTIVENESS RATIO; NET HEALTH BENEFIT; NON-PARAMETRIC STATISTICAL METHODS; SKEWNESS;

COST BENEFIT ANALYSIS;

BOOTSTRAPPING; CONFIDENCE INTERVAL; COST-BENEFIT ANALYSIS; HEALTH CARE; SIMULATION; SKEWNESS; STATISTICAL ANALYSIS;

ACCURACY; ARTICLE; BOOSTRAP PERCENTILE INTERVAL; BOOTSTRAP BIAS CORRECTED ACCELERATION INTERVAL; CONFIDENCE INTERVAL; COST EFFECTIVENESS ANALYSIS; EVALUATION; FIELLER INTERVAL; HEALTH; INCREMENTAL COST EFFECTIVENESS RATIO; INFERENTIAL STATISTICS; INTERMETHOD COMPARISON; NET HEALTH BENEFIT; NONPARAMETRIC TEST; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PERFORMANCE; SIMULATION; STATISTICAL ANALYSIS; STUDENT T TEST; SYSTEMATIC ERROR; TAYLOR INTERVAL; THEORY;

EID: 33745248689     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2006.00509.x     Document Type: Article

References (28)

1. Briggs A. ( 1999). A Bayesian approach to stochastic cost-effectiveness analysis. Health Economics 8, 257 261.
2. Briggs A. and Fenn P. ( 1998). Confidence intervals or surfaces¿ Uncertainty on the cost-effectiveness plane. Health Economics 7, 723 740.
3. Briggs A. Mooney C., and Wonderling D. ( 1999). Constructing confidence intervals for cost-effectiveness ratios: An evaluation of parametric and non-parametric techniques using Monte Carlo simulation. Statistics in Medicine 18, 3245 3262.
4. Chaudhary M. and Stearns S. ( 1996). Estimating confidence intervals for cost-effectiveness ratios: An example from a randomized trial. Statistics in Medicine 15, 1447 1458.
5. Fieller E. ( 1954). Some problems in interval estimation. Journal of the Royal Statistical Society, Series B 16, 175 183.
6. Garber A. and Phelps C. ( 1997). Economic foundations of cost-effectiveness analysis. Journal of Health Economics 16, 1 31.
7. Gardiner J. Hogan A. Holmes-Rovner M. Griffith L., and Kupersmith J. ( 1995). Confidence intervals for cost-effectiveness ratios. Medical Decision Making 15, 254 263.
8. Gardiner J. Huebner M. Jetton J., and Bradley C. ( 2001). On parametric confidence intervals for the cost-effectiveness ratio. Biometrical Journal 43, 283 296.
9. Hall P. ( 1992a). The Bootstrap and Edgeworth Expansion. New York : Springer.
10. Hall P. ( 1992b). On the removal of skewness by transformation. Journal of the Royal Statistical Society, Series B 54, 221 228.
11. Hall P. and Martin M. ( 1988). On the bootstrap and two-sample problems. Australian Journal of Statistics 30A, 179 192.
12. Hinkley D. ( 1969). On the ratio of two correlated normal random variables. Biometrika 56, 635 639.
13. Jiang G. Wu J., and Williams R. ( 2000). Fieller's interval and the bootstrap-Fieller interval for the incremental cost-effectiveness ratio. Health Services and Outcome Research Methodology 1, 291 303.
14. Katon W. Roy-Byrne P. Russo J., and Cowley D. ( 2002). Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Archives of General Psychiatry 59, 1098 1104.
15. Kobelt G. Jonsson L. Young A., and Eberhardt K. ( 2003). The cost-effectiveness of infliximab (remicade) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study. Rheumatology 42, 326 335.
16. Laska E. Meisner M., and Siegel C. ( 1997). Statistical inference for cost-effectiveness ratios. Health Economics 6, 229 242.
17. O'Brien B. Drummond M. Labelle R., and Willan A. ( 1994). In search of power and significance: Issues in the design and analysis of stochastic cost-effectiveness studies in health care. Medical Care 32, 150 163.
18. O'Hagan A. Stevens J., and Montmartin J. ( 2001). Bayesian cost-effectiveness analysis from clinical trial data. Statistics in Medicine 20, 733 753.
19. Pasha T. Gabriel S. Therneau T. Dickson E., and Lindor K. ( 1998). Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology 27, 1220 1226.
20. Polsky D. Glick H. Willke R., and Schulman K. ( 1997). Confidence intervals for cost-effectiveness ratios: A comparison of four methods. Health Economics 6, 243 252.
21. Saywell R. Champion V. Skinner C. McQuillen D. Martin D., and Maraj M. ( 1999). Cost-effectiveness comparison of five interventions to increase mammography screening. Preventive Medicine 29, 374 382.
22. Stinnett A. and Mullahy J. ( 1998). Net health benefit: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making 18, S68 S80.
23. Sullivan S. Lee T. Blough D. Finkelstein J. Lozano P. Inui T. Fuhlbrigge A. Carey V. Wagner E., and Weiss K. ( 2005). A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: Cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II). Archives of Pediatrics and Adolescent Medicine 159, 428 434.
24. Willan A. ( 2001). Analysis, sample size, and power for estimating incremental net health benefit from clinical trial data. Controlled Clinical Trials 22, 228 237.
25. Willan A. ( 2003). Analysing cost-effectiveness trials: Net benefits. In Statistical Methods for Cost-Effectiveness Research: A Guide to Current Issues and Future Development A. Briggs ( ed 8 23. London : Office of Health Economics.
26. Willan A. and O'Brien B. ( 1996). Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem. Health Economics 5, 297 305.
27. Zethraeus N. Johannesson M. Jonsson B., and Lothgren M. ( 2003). Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies. Pharmacoeconomics 21, 39 48.
28. Zhou X.-H. and Dinh P. ( 2005). Nonparametric confidence intervals for the one- and two-sample problems. Biostatistics 6, 187 200.